Cite
HARVARD Citation
Wiendl, H. et al. (2021). Real-world disability improvement in patients with relapsing–remitting multiple sclerosis treated with natalizumab in the Tysabri Observational Program. Multiple sclerosis. pp. 719-728. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wiendl, H. et al. (2021). Real-world disability improvement in patients with relapsing–remitting multiple sclerosis treated with natalizumab in the Tysabri Observational Program. Multiple sclerosis. pp. 719-728. [Online].